par ten Bokkel Huinink, Wim;Prove, A M;Piccart-Gebhart, Martine
;Steward, W;Tursz, T;Wanders, Jantien;Franklin, H;Clavel, Michel;Verweij, Jaap;Alakl, M
Référence Annals of oncology, 5, 6, page (527-532)
Publication Publié, 1994-07

Référence Annals of oncology, 5, 6, page (527-532)
Publication Publié, 1994-07
Article révisé par les pairs
Titre: |
|
Auteur: | ten Bokkel Huinink, Wim; Prove, A M; Piccart-Gebhart, Martine; Steward, W; Tursz, T; Wanders, Jantien; Franklin, H; Clavel, Michel; Verweij, Jaap; Alakl, M |
Informations sur la publication: | Annals of oncology, 5, 6, page (527-532) |
Statut de publication: | Publié, 1994-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Breast cancer |
Docetaxel | |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Agents, Phytogenic -- administration & dosage | |
Antineoplastic Agents, Phytogenic -- adverse effects | |
Antineoplastic Agents, Phytogenic -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Drug Administration Schedule | |
Drug Eruptions -- etiology | |
Europe | |
Female | |
Humans | |
Middle Aged | |
Nervous System Diseases -- chemically induced | |
Neutropenia -- chemically induced | |
Paclitaxel -- administration & dosage | |
Paclitaxel -- adverse effects | |
Paclitaxel -- analogs & derivatives | |
Paclitaxel -- therapeutic use | |
Remission Induction | |
Taxoids | |
Note générale: | Clinical Trial |
Clinical Trial, Phase II | |
Journal Article | |
Multicenter Study | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:scp/0028260937 | |
info:pmid/7918124 |